(Total Views: 731)
Posted On: 07/13/2020 8:13:34 AM
Post# of 153903
Dave,
I completely understand and agree with you, and thank you for sharing that info for the folks who don't understand how these convoluted processes work, examples like that need to be given. Mine was intended to be more of a sarcastic statement, kind of an eye roll so to speak to the negative sp promoters. Instead of the FDA dividing their time proportionally between the indications as the did a year ago, now they are 90 percent covid and everything else splits the remaining 10 % imo. So to see more RFIs and delays in HIV doesn't surprise me. Its like everything else, covid is directing the traffic. If we hit 10 to 15 by the end of the month on trial data then covid approval to 20 or 25 four to 6 weeks after that no one will say a word about Nader or the FDA requesting something else on HIV, thats just the way it is.
I completely understand and agree with you, and thank you for sharing that info for the folks who don't understand how these convoluted processes work, examples like that need to be given. Mine was intended to be more of a sarcastic statement, kind of an eye roll so to speak to the negative sp promoters. Instead of the FDA dividing their time proportionally between the indications as the did a year ago, now they are 90 percent covid and everything else splits the remaining 10 % imo. So to see more RFIs and delays in HIV doesn't surprise me. Its like everything else, covid is directing the traffic. If we hit 10 to 15 by the end of the month on trial data then covid approval to 20 or 25 four to 6 weeks after that no one will say a word about Nader or the FDA requesting something else on HIV, thats just the way it is.
(2)
(0)
